MLBBO.PA BEBO Health SA

Consumer Cyclical Specialty Retail Euronext Paris
0.1680 EUR
Close of Oct 28, 2026
0.1400 0.2300
Market cap
EUR 119M
P/E
-
P/B
7.45x
ROE
0.3%
Dividend yield
-
Fundamental score
2.0/5

Ratios use the latest price and the fiscal year ending Dec 2025.

Is MLBBO.PA undervalued?

Graham number

The Graham number of BEBO Health SA cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

BEBO Health SA fundamental analysis

5 of 11 checks passed

ROE 2/2

ROE surpassing expectations (82.15%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

ROA 2/2

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

PBV 0/2

The stock's elevated P/BV ratio (191.12x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

DER 0/2

The stock is burdened with a heavy load of debt (186%), making it financially unstable and potentially risky for investors.

Revenue Growth 2/2

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

Net Profit Growth 0/2

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

Assets Growth 1/2

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

Graham Number 0/1

The company's Graham number indicates that it is overvalued compared to its stock price, suggesting a potentially unfavorable investment opportunity.

Dividend Growth 0/2

Investors should note the company's stagnant dividend growth over the past three years, indicating limited profitability and potentially diminishing returns.

Dividend 0/2

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Buffet Intrinsic Value 1/1

Based on Warren Buffett's formula, the company's stock appears undervalued (106), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

BEBO Health SA stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About BEBO Health SA

BEBO Health SA operates an e-commerce portal for products related to health, sports, and well-being. The company was founded in 2019 and is based in Geneva, Switzerland. BEBO Health SA operates as a subsidiary of CES Management SA.

Full company profile